Fig. 1From: Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?Overall survival* of patients who underwent radioembolization bridging treatment in comparison to patients who underwent TACE bridging treatment (p = 0.1522). *reference point for calculation of survival: day of liver transplantation (= day 0)Back to article page